Off-label use of intravenous immunoglobulin for neurological conditions a review of clinical effectiveness
The purpose of this Rapid Response Report is to collect, critically appraise and evaluate the current evidence on the clinical effectiveness off-label use of intravenous immunoglobulin for the treatment of neurological or neuromuscular conditions. This report is a full-text review of studies origina...
| Main Authors: | , |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa
CADTH
2018, March 14, 2018
|
| Edition: | Version: 1.0 |
| Series: | CADTH rapid response report: summary with critical appraisal
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | The purpose of this Rapid Response Report is to collect, critically appraise and evaluate the current evidence on the clinical effectiveness off-label use of intravenous immunoglobulin for the treatment of neurological or neuromuscular conditions. This report is a full-text review of studies originally identified in the CADTH Rapid Response Summary of Abstracts report: Off-Label Use of Intravenous Immunoglobulin for Neurological Conditions |
|---|---|
| Physical Description: | 1 PDF file (70 pages) illustration |